Cargando…
When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report
BACKGROUND: Long-term survival with durable response remains possible in the area of targeted therapies. Discontinuation of sunitinib could improve quality of life and reduce treatment costs in metastatic renal cell carcinoma with long-term disease stabilization. We discuss a case of successful inte...
Autores principales: | Sbitti, Yassir, Debbagh, Adil, Slimani, Khaoula, Mahi, Mohamed, Errihani, Hassan, Ichou, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859488/ https://www.ncbi.nlm.nih.gov/pubmed/29554941 http://dx.doi.org/10.1186/s13256-018-1597-z |
Ejemplares similares
-
Renal damage induced by pemetrexed causing drug discontinuation: a case report and review of the literature
por: Sbitti, Yassir, et al.
Publicado: (2017) -
Visceral Crisis Means Short Survival Among Patients With Luminal A Metastatic Breast Cancer: A Retrospective Cohort Study
por: Sbitti, Yassir, et al.
Publicado: (2017) -
Metachronous pancreatic metastases from renal cell carcinoma: is there a place of Active-Surveillance before deferred deliberately Molecular Target Agent?
por: Sbitti, Yassir, et al.
Publicado: (2016) -
Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?
por: Sbitti, Yassir, et al.
Publicado: (2011) -
Treatment of Liver Metastases From Colorectal Cancer: Medico-Surgical Strategies
por: Essadi, Ismail, et al.
Publicado: (2011)